中集安瑞科(03899) - 2022 - 年度业绩

Financial Performance - Revenue for the year ended December 31, 2022, was RMB 19,601,761 thousand, representing a 6.4% increase from RMB 18,424,763 thousand in 2021[1] - Net profit for 2022 was RMB 1,084,938 thousand, up 19.4% from RMB 908,392 thousand in 2021[2] - Core profit increased by 29.4% to RMB 1,227,963 thousand from RMB 948,846 thousand in the previous year[1] - Basic earnings per share rose to RMB 0.528, an 18.1% increase compared to RMB 0.447 in 2021[2] - Gross profit margin improved to 17.4%, up 2.7 percentage points from 14.7% in 2021[1] - The total comprehensive income for the period was RMB 996,466 thousand, with a significant contribution from the annual profit of RMB 1,055,062 thousand[7] - The company reported a pre-tax profit of RMB 1,398,302 thousand in 2022, up from RMB 1,139,557 thousand in 2021, an increase of about 22.73%[22] Assets and Liabilities - Total assets as of December 31, 2022, were RMB 22,214,474 thousand, compared to RMB 19,024,673 thousand in 2021[4] - Total liabilities increased to RMB 12,686,967 thousand from RMB 10,524,996 thousand in the previous year[5] - The total assets for reportable segments increased to RMB 20,817,892 thousand in 2022 from RMB 17,876,488 thousand in 2021, marking an increase of approximately 16.4%[28] - The total liabilities for reportable segments rose to RMB 10,389,208 thousand in 2022, up from RMB 8,344,924 thousand in 2021, indicating a growth of about 24.5%[29] Cash Flow and Investments - Cash and cash equivalents rose significantly to RMB 5,223,453 thousand, up from RMB 3,173,351 thousand in 2021[4] - Operating cash inflow for the year was RMB 2,561,009,000, significantly higher than RMB 434,651,000 in 2021, primarily due to an increase in contract liabilities[53] - The group invested RMB 501,722,000 in capital expenditures in 2022, a decrease from RMB 841,019,000 in 2021, focusing on capacity enhancement and new business[59] Revenue Breakdown - Sales of goods contributed RMB 12,832,262 thousand to the total revenue, up from RMB 11,870,349 thousand in 2021, representing a growth of 8.1%[13] - The revenue from engineering project contracts was RMB 6,769,499 thousand, compared to RMB 6,554,414 thousand in the previous year, marking an increase of 3.3%[13] - Revenue from external customers in China was RMB 8,995,216 thousand in 2022, a slight decrease from RMB 9,095,732 thousand in 2021[31] - The company reported a significant increase in revenue from the United States, rising to RMB 2,121,782 thousand in 2022 from RMB 1,260,730 thousand in 2021, representing a growth of approximately 68.3%[31] Dividends - The company proposed a final dividend of HKD 0.24 per share, a 14.3% increase from HKD 0.21 in 2021[1] - The board of directors proposed a final dividend of HKD 0.24 per share for the year ending December 31, 2022, compared to HKD 0.21 per share in 2021, maintaining a payout ratio of approximately 40%[79] - The dividend will be paid in cash on or around June 28, 2023, subject to shareholder approval at the annual general meeting on May 17, 2023[79] Employee Costs - Employee costs rose to RMB 2,051,266 thousand in 2022, compared to RMB 1,845,566 thousand in 2021, representing an increase of 11.2%[18] - As of December 31, 2022, the total number of employees in the group was approximately 10,500, an increase from about 9,900 in 2021, with total employee costs amounting to RMB 2,051,266 thousand, up from RMB 1,845,566 thousand in 2021[60] Segment Performance - The clean energy segment revenue decreased by 5.5% to RMB 10,591,120 in 2022 from RMB 11,210,471 in 2021[43] - The chemical environment segment revenue increased by 38.2% to RMB 5,241,667 in 2022 from RMB 3,793,827 in 2021[43] - The liquid food segment's revenue rose by 5.8% to RMB 3,619,638, making up 18.5% of total revenue, slightly down from 18.6% in 2021[46] Future Outlook and Strategy - The group is focusing on expanding LNG import terminals in Europe and Asia, creating new opportunities for suppliers in sub-Saharan Africa[70] - The group is actively developing new markets such as white spirits and biopharmaceuticals, securing initial orders in these sectors[69] - The company plans to focus on breakthroughs in hydrogen production technologies, including blue and green hydrogen, and aims to establish production bases in Jiangsu and Hebei[75] Corporate Governance - The company has adhered to all corporate governance codes as stipulated by the Hong Kong Stock Exchange during the fiscal year ending December 31, 2022[83] - The audit committee has reviewed the group's annual performance and consolidated financial statements for the year ended December 31, 2022[84] - The independent auditor confirmed that the figures reported in the group's performance announcement for the year ended December 31, 2022, are consistent with the audited consolidated financial statements[85]